Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
TrippBio is a new biotechnology company focused on developing innovative applications of existing drugs to prevent and treat rogue viruses starting with the SARS-CoV-2 virus that causes COVID-19.
Repurposing an FDA approved drug, TD213
Works on therapeutic treatments for respiratory diseases that work with your body’s natural defenses.
The global antivirals market is expected to reach $75 Bn by 2023
Opportunities by Industry
eSports | Backers is restructuring eSports competitions by creating crowd-funded prize pools on the Ethereum blockchain. Fans gain a form of equity in the team during the competition and receive their share of the prize pool when their teams win.
Cryptocurrency | Monetran has developed an asset-backed, redeemable, stable token. Their system is designed to cost 70% less than traditional money transfers, and to cut the time of delivery down from days to a mere 3-5 seconds.
🤝 FinTech | Demand Derivatives Corp. is the parent company for the forthcoming innovative, vertically integrated futures exchange RealDemand Board of Trade (“RealBOT™”) and its dedicated clearing house RealDemand Clearing (“RealClear™”) (upon CFTC and SEC approval) destined to trade the world’s major assets in a creative new way.